Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
ABL Texcell Diagnostics said it signed a non-binding letter of intent to acquire 100% of Vela Diagnostics' activities in Singapore and the U.S. There will be no change in control or governance of ABL Texcell Diagnostics or Advanced Biological Laboratories.
ABL Diagnostics reported no change in control and governance of ABL Texcell Diagnostics or Advanced Biological Laboratories Luxembourg.
ABL Texcell Diagnostics has signed a non-binding letter of intent to acquire 100% of Vela Operations Singapore and Vela Diagnostics USA. The company aims to consolidate an integrated international platform covering EMEA, Asia-Pacific, and the United States.